world cancer report - iarc

Fig. 3.5 Pedunculated hyperplastic polyp of the
colon.
REFERENCES
1. Foulds L, ed. (1969) Neoplastic Development, Vol. 1,
London, Academic Press.
2. Correa P (1996) Morphology and natural history of cancer
precursors. In: Schottenfeld D, Fraumeni JF, eds,
Cancer Epidemiology and Prevention, New York, Oxford
University Press, 45-64.
3. Ito N, Imaida K, Asamoto M, Shirai T (2000) Early
detection of carcinogenic substances and modifiers in rats.
Mutat Res, 462 : 209-217.
4. Weinstein IB (1982) Carcinogenesis as a multistage
process—experimental evidence. In: Bartsch H, Armstong
B, eds, Host Factors in Human Carcinogenesis (IARC
Scientific Publications No. 39) Lyon, IARCPress, 9-25.
5. Vainio H, Magee PN, McGregor DB, McMichael AJ, eds
(1992) Mechanisms of Carcinogenesis in Risk Identification
(IARC Scientific Publications No. 116), Lyon, IARCPress.
6. Yamasaki H, Ashby J, Bignami M, Jongen W, Linnainmaa
K, Newbold RF, Nguyen-Ba G, Parodi S, Rivedal E,
Schiffmann D, Simons JW, Vasseur P (1996) Nongenotoxic
carcinogens: development of detection methods based on
88 Mechanisms of tumour development
cer (see chapter 4). The fact that particular
patterns of cell morphology and
growth precede emergence of an
unequivocally malignant cell population
is the basis of secondary prevention of
cancer.
Examples include detection of polyps in
the large bowel (Fig. 3.5) and of morphological
change which is the basis of the
Papanicolaou smear test for early detection
of cervical cancer. Moreover, dietary
or pharmaceutical interventions calculated
to prevent or reverse such lesions are
the basis of chemoprevention [16]. Most
importantly, knowledge of the genetic
basis underlying tumour growth should
provide new criteria for individual determination
of diagnosis and prognosis. The
mechanisms: a European project. Mutat Res, 353: 47-63.
7. Vogelstein B, Fearon ER, Hamilton SR, Kern SE,
Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM,
Bos JL (1988) Genetic alterations during colorectal-tumor
development. N Engl J Med, 319: 525-532.
8. Balmain A, Harris CC (2000) Carcinogenesis in mouse
and human cells: parallels and paradoxes. Carcinogenesis,
21: 371-377.
9. Evan GI, Vousden KH (2001) Proliferation, cell cycle
and apoptosis in cancer. Nature, 411: 342-348.
10. Loeb LA (2001) A mutator phenotype in cancer.
Cancer Res, 61: 3230-3239.
11. Hahn WC, Counter CM, Lundberg AS, Beijersbergen
RL, Brooks MW, Weinberg RA (1999) Creation of human
tumour cells with defined genetic elements. Nature, 400:
464-468.
12. Esteller M, Corn PG, Baylin SB, Herman JG (2001) A
gene hypermethylation profile of human cancer. Cancer
Res, 61: 3225-3229.
mechanisms now known to operate in
the proliferation of cancer cells provide a
basis for the development of new, more
efficient therapies without the sideeffects
that currently often afflict cancer
patients [17].
13. Marnett LJ, Plastaras JP (2001) Endogenous DNA
damage and mutation. Trends Genet, 17: 214-221.
14. Armitage P, Doll R (1954) The age distribution of cancer
and a multistage theory of carcinogenesis. Br J Cancer,
8: 1-12.
15. Wynford-Thomas D (1999) Cellular senescence and
cancer. J Pathol, 187: 100-111.
16. Bartsch H (2000) Studies on biomarkers in cancer
etiology and prevention: a summary and challenge of 20
years of interdisciplinary research. Mutat Res, 462: 255-
279.
17. Kallioniemi OP, Wagner U, Kononen J, Sauter G
(2001) Tissue microarray technology for high-throughput
molecular profiling of cancer. Hum Mol Genet, 10: 657-
662.